TGFB1 and pulmonary fibrosis: Moreover, Gu et al. recently demonstrated the efficacy of baricitinib in the attenuation of pulmonary fibrosis in mice through the suppression of TGF-β1-mediated fibroblast activation and epithelial injury [55].